Posted by Michael Wonder on 21 May 2025
ICER to assess treatment for smoking cessation
20 May 2025 - Report will be subject of Midwest CEPAC meeting in January 2026; draft scoping document open to public comment until 10 June 2025.
The ICER announced today that it will assess the comparative clinical effectiveness and value of cytisinicline (Achieve Life Sciences) for smoking cessation.
